Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Summary

This study will evaluate the effectiveness and safety of an investigational drug, IV ganaxolone, as adjunctive therapy to standard of care to treat subjects with status epilepticus.

Timeline

Start

2018-02-19

Primary completion

2019-09-18

Completion

2019-09-18

Publications

• Vaitkevicius H, Ramsay RE, Swisher CB, Husain AM, Aimetti A, Gasior M. Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial. Epilepsia. 2022 Sep;63(9):2381-2391. doi: 10.1111/epi.17343. Epub 2022 Jul 10.

Drugs

Indications